Prosight Management, LP Molecular Templates, Inc. Transaction History

Prosight Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $1.82 Million - $2.94 Million	-160,883 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.44 - $14.21 $399,994 - $882,597	-62,111 Reduced 27.85%	160,883 $2.25 Million
Q3 2019 Nov 14, 2019	BUY	$4.6 - $8.46 $116,439 - $214,147	25,313 Added 12.8%	222,994 $1.47 Million
Q2 2019 Aug 14, 2019	SELL	$5.83 - $8.42 $583,635 - $842,917	-100,109 Reduced 33.62%	197,681 $1.65 Million
Q1 2019 May 15, 2019	BUY	$4.02 - $5.81 $1.2 Million - $1.73 Million	297,790 New	297,790 $1.73 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.